Related Experiment Video
Updated: Aug 8, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Scleroderma Renal Crisis in Mixed Connective Tissue Disease
Indira Acharya1, Onyekachi Ibe-Ejiogu2, Ashik Pokharel3
1Department of Rheumatology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Scleroderma renal crisis, a rare complication in mixed connective tissue disease, involves hypertension and anemia. Early ACE inhibitor treatment is key, but many still need dialysis or transplant.
Area of Science:
- Nephrology
- Rheumatology
- Vascular Medicine
Background:
- Scleroderma renal crisis (SRC) is a severe vascular complication typically seen in systemic sclerosis.
- SRC occurrence in mixed connective tissue disease (MCTD) is exceptionally rare, with only 10 cases documented.
- Pathogenesis involves endothelial damage, intimal hyperplasia, and arteriolar narrowing, causing malignant hypertension and hemolytic anemia.
Purpose of the Study:
- To highlight the rare occurrence and clinical features of scleroderma renal crisis in mixed connective tissue disease.
- To emphasize the importance of early diagnosis and prompt management of SRC in MCTD patients.
- To review current and emerging therapeutic strategies for SRC.
Main Methods:
- Literature review of reported cases of SRC in MCTD.
- Analysis of pathogenesis, clinical presentation, and management strategies.
- Discussion of treatment outcomes and prognosis.
Main Results:
- Malignant hypertension and microangiopathic hemolytic anemia are key features of SRC in MCTD.
- Angiotensin-converting enzyme inhibitors (e.g., captopril) are the cornerstone of initial management.
- Despite treatment, a significant proportion of patients develop end-stage renal disease, requiring renal replacement therapy.
Conclusions:
- Early recognition and intervention for SRC in MCTD are critical for improving patient outcomes.
- While ACE inhibitors are vital, refractory cases may benefit from novel therapies like endothelin receptor antagonists or complement inhibitors.
- Increased awareness among clinicians is essential for timely diagnosis and management of this rare but serious condition.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Rheumatic Heart Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management